Tweet about this on TwitterShare on FacebookShare on LinkedIn

February 3, 2016

The Seattle Times

February 2, 2016

Two Washington state insurers — Group Health Cooperative and BridgeSpan — are targeted in class-action lawsuits that claim the companies are unfairly rationing new drugs that can cure hepatitis C based on high cost, not medical need.

Read the full story here.